Open Outbreak

Plague

Also known as: Yersinia pestis, bubonic plague, pneumonic plague, septicaemic plague

Plague is a serious bacterial infection caused by Yersinia pestis. The bacteria persist in small mammals and their fleas. People can become infected through flea bites, contact with infected animal tissues or bodily fluids, or breathing respiratory particles from someone with pneumonic plague. Bubonic plague causes painful, swollen lymph nodes. Septicaemic plague affects the bloodstream, while pneumonic plague affects the lungs and can spread between people. Symptoms usually begin one to seven days after infection, although pneumonic plague can develop sooner. Without treatment, plague can be fatal, especially when it affects the lungs or bloodstream. Early antibiotics and supportive care can save lives. Public-health responses include finding cases quickly, following close contacts, providing preventive antibiotics when indicated, and controlling fleas and animal sources. Vaccine availability was not established by the sources retrieved for this page. Plague remains present in several countries. WHO reports that most human cases reported during 2019–2025 occurred in the Democratic Republic of the Congo and Madagascar.

Key facts

TransmissionInfected flea bites; contact with infected tissues, bodily fluids or contaminated materials; inhalation of respiratory particles from someone with pneumonic plague. Human-to-human spread of bubonic plague is rare.
IncubationUsually 1–7 days; pneumonic plague can have an incubation as short as 24 hours, with WHO also describing symptoms sometimes appearing sooner.
Case fatalityWHO reports 30–60% for untreated bubonic plague and describes untreated pneumonic and septicaemic plague as invariably fatal unless treated early. A general treated case-fatality estimate is unknown from the retrieved sources.
Reproduction numberunknown
Vaccineunknown: current vaccine approval, availability and recommendations were not established by the retrieved sources.
TreatmentPrompt antibiotics and supportive care. Close contacts may receive preventive antibiotics under public-health guidance.
ReservoirSmall mammals, including rodents, with associated fleas maintaining transmission.
Endemic regionsNatural disease foci occur in the Americas, Africa and Eurasia. Most human cases reported to WHO during 2019–2025 occurred in the Democratic Republic of the Congo and Madagascar.

Transmission

Plague normally circulates between small mammals and their fleas. People can become infected when an infected flea bites them or when they have unprotected contact with infected tissues, bodily fluids or contaminated materials. Pneumonic plague affects the lungs and can spread between people through respiratory particles. It can develop after inhaling those particles or when another form of plague spreads to the lungs. Human-to-human transmission of bubonic plague is rare. These differences matter: a cluster of lung infections requires attention to close contacts as well as animal and flea exposure. The retrieved sources do not establish a reproduction number or a reliable secondary attack rate.

Symptoms and severity

Symptoms usually begin one to seven days after infection. Pneumonic plague can develop in about 24 hours or sooner. Bubonic plague commonly causes sudden fever, chills, headache, weakness, nausea and painful swollen lymph nodes, called buboes. Lung infection can cause shortness of breath and coughing, sometimes with blood-stained sputum. Bloodstream infection can cause bleeding under the skin, tissue damage and organ failure. WHO gives an untreated fatality range of 30–60% for bubonic plague and describes untreated pneumonic and septicaemic plague as invariably fatal unless treated early. These figures are not estimates for promptly treated patients. Fever with painful swollen nodes or breathing symptoms after a plausible exposure warrants urgent medical assessment.

Treatment and vaccines

Plague is treated with antibiotics and supportive care. Speed matters, particularly for pneumonic plague: WHO says untreated lung infection can be fatal within 18–24 hours of disease onset. Early treatment substantially improves the chance of recovery. The retrieved material does not provide a general fatality estimate for treated patients. Public-health teams also identify and follow close contacts and may give preventive antibiotics. In Madagascar’s 2021 outbreak response, contacts received cotrimoxazole or doxycycline. Drug choice should be made by clinicians, not copied from an outbreak report for self-treatment. Current vaccine approval and availability were not established by the retrieved sources, so this page cannot describe vaccination as an available preventive option.

Where it occurs

Plague persists in natural animal populations rather than only during human outbreaks. A 2020 review describes established natural disease areas in the Americas, Africa and Eurasia. WHO states that animal plague occurs on all continents except Oceania. Human risk arises where infected animals, their fleas and people overlap. During 2019–2025, most human cases reported to WHO occurred in the Democratic Republic of the Congo and Madagascar. In Madagascar, cases occur nearly every year, with the usual transmission season running from September through April. WHO’s 2021 notice identifies the central highlands as a recurring setting. A country reporting no human cases may still have animal populations carrying plague.

Recent history

As of this page’s reference date, 2026-11-15, Open Outbreak lists 24 archived plague events, combining WHO notices since 1996 with major historical pandemics. This is a site archive count, not a count of all outbreaks worldwide. The archive includes Madagascar’s 2017 epidemic, notable for its size and spread in cities, and WHO notices for the Democratic Republic of the Congo on 2020-07-23 and Madagascar on 2021-10-01. The latter reported 20 suspected and 22 confirmed cases as of 2021-09-15, with eight deaths among confirmed cases. The supplied site record labels the Irkutsk Oblast plague scare as monitoring; the retrieved documents do not confirm an outbreak there. No later WHO notice was returned in this search.

What to watch

Important warning signals include confirmed cases in new regions, spread into densely populated cities, and clusters of pneumonic plague suggesting person-to-person transmission. Madagascar’s unusual urban epidemic in 2017 shows why the location and form of disease matter. Delays in diagnosis, treatment or contact follow-up also deserve attention because lung infection can worsen rapidly. Animal surveillance can identify infected rodents and changes in flea abundance. Resistance that makes recommended antibiotics less effective would be concerning, but the retrieved sources do not establish a current resistance trend. Vaccine supply cannot be assessed from these sources either. More immediately, shortages of antibiotics, diagnostic capacity or response resources could hinder the measures WHO describes.

Related outbreaks

Updated